Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP787426.RASiNUWbSLx20cQSNslZpG84G7QKvzf2WgC9NGUvpF0Sg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP787426.RASiNUWbSLx20cQSNslZpG84G7QKvzf2WgC9NGUvpF0Sg130_assertion type Assertion NP787426.RASiNUWbSLx20cQSNslZpG84G7QKvzf2WgC9NGUvpF0Sg130_head.
- NP787426.RASiNUWbSLx20cQSNslZpG84G7QKvzf2WgC9NGUvpF0Sg130_assertion description "[Compounds that inhibit kinase activity are effective growth inhibitors for poorly differentiated thyroid cancer cell lines with either RET or RAF mutations, and hold promise for treatment of most forms of papillary thyroid carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP787426.RASiNUWbSLx20cQSNslZpG84G7QKvzf2WgC9NGUvpF0Sg130_provenance.
- NP787426.RASiNUWbSLx20cQSNslZpG84G7QKvzf2WgC9NGUvpF0Sg130_assertion evidence source_evidence_literature NP787426.RASiNUWbSLx20cQSNslZpG84G7QKvzf2WgC9NGUvpF0Sg130_provenance.
- NP787426.RASiNUWbSLx20cQSNslZpG84G7QKvzf2WgC9NGUvpF0Sg130_assertion SIO_000772 16551863 NP787426.RASiNUWbSLx20cQSNslZpG84G7QKvzf2WgC9NGUvpF0Sg130_provenance.
- NP787426.RASiNUWbSLx20cQSNslZpG84G7QKvzf2WgC9NGUvpF0Sg130_assertion wasDerivedFrom befree-20140225 NP787426.RASiNUWbSLx20cQSNslZpG84G7QKvzf2WgC9NGUvpF0Sg130_provenance.
- NP787426.RASiNUWbSLx20cQSNslZpG84G7QKvzf2WgC9NGUvpF0Sg130_assertion wasGeneratedBy ECO_0000203 NP787426.RASiNUWbSLx20cQSNslZpG84G7QKvzf2WgC9NGUvpF0Sg130_provenance.